Spotlight Innovation
is a pharmaceutical company that identifies and acquires rights to proprietary technologies such as cancer drugs and therapies... Read moreSpotlight Innovation
is a pharmaceutical company that identifies and acquires rights to proprietary technologies such as cancer drugs and therapies... Read more
Interim-CEO
John M. Krohn
News
Nov 05, 2018
BioPortfolio
Spotlight Innovation: Spotlight Innovation Inc STLT Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23102018 Prices from USD $250
Oct 11, 2018
Market Exclusive
Spotlight Innovation: Spotlight Innovation Inc. (OTCMKTS:STLT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Aug 17, 2018
Market Exclusive
Spotlight Innovation: Spotlight Innovation Inc. (OTCMKTS:STLT) Files An 8-K Changes in Registrant's Certifying Accountant
Jul 29, 2018
BioPortfolio
Spotlight Innovation: Spotlight Innovation Inc STLT Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250
Jul 24, 2018
NewMediaWire
Press Release: Spotlight Innovation : Spotlight Innovation Spinal Muscular Atrophy Research Collaborator Professor Kevin Hodgetts Receives $300,000 Grant from Cure SMA
Jul 10, 2018
Central Charts
Spotlight Innovation: Spotlight Innovation Announces Partnership Agreement with At-Risk Youth Organization Hip-Hope
Jun 20, 2018
Market Exclusive
Spotlight Innovation: Spotlight Innovation Inc. (OTCMKTS:STLT) Files An 8-K Other Events
Jun 12, 2018
NewMediaWire
Press Release: Spotlight Innovation : Article Co-authored by Spotlight Innovation Research Collaborator Describes Small Molecule Drugs with In-vivo Efficacy Against Zika Virus Infection
May 10, 2018
BioPortfolio
Spotlight Innovation: Spotlight Innovation Inc STLT Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250
Apr 18, 2018
NewMediaWire
Press Release: Spotlight Innovation : Spotlight Innovation Subsidiary Celtic Biotech Iowa Announces Results from Two Cohorts of Phase I Trial of Crotoxin for the Treatment of Cancer
Spotlight Innovation Competitors
1
2
3
4
5
6
7
8
9